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Adenosine (Ado) mediates vasoconstriction via A1-Ado
receptors and vasodilation via A2-Ado receptors in the kidney.
It interacts with angiotensin II (Ang II), which is important for
renal hemodynamics and tubuloglomerular feedback (TGF).
The aim was to investigate the function of Ado receptors in
the Ado–Ang II interaction in mouse microperfused, afferent
arterioles. Ado (1011–104 mol/l) caused a biphasic response:
arteriolar diameters were reduced (7%) at Ado
1011–109 mol/l and returned to control values at higher
concentrations. Treatment with Ang II (1010 mol/l)
transformed the response into a concentration-dependent
constriction. N6-cyclopentyladenosine (A1-Ado receptor
agonist) reduced diameters (12% at 106 mol/l). Application of
CGS21680 (1012–104 mol/l, A2A receptor agonist) increased
the diameter by 13%. Pretreatment with ZM241385 (A2A-Ado
receptor antagonist) alone or in combination with MRS1706
(A2B-Ado receptor antagonist) resulted in a pure constriction
upon Ado, whereas 8-cyclopentyltheophylline (CPT) (A1-Ado
receptor antagonist) inhibited the constrictor response.
Afferent arterioles of mice lacking A1-Ado receptor did not
show constriction upon Ado. Treatment with Ado (108 mol/l)
increased the response upon Ang II, which was blocked by
CPT. Ado (105 mol/l) did not influence the Ang II response,
but an additional blockade of A2-Ado receptors enhanced it.
The action of Ado on constrictor A1-Ado receptors and
dilatory A2-Ado receptors modulates the interaction with
Ang II. Both directions of Ado–Ang II interaction, which
predominantly leads to an amplification of the contractile
response, are important for the operation of the TGF.
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The purine nucleoside adenosine (Ado) causes vasodilation
in several organs, including the brain and heart, but a
transient vasoconstriction in the kidney.1–3 The fact that Ado
is formed during increased cellular metabolism and causes
vasoconstriction in kidney suggests that Ado mediates
tubuloglomerular feedback (TGF).4–7 The recent observation
of a complete loss of TGF in micropuncture studies of
A1(/) mice provides additional proof.8,9
Although there is agreement about the general potency
of Ado to induce vasoconstriction in the renal resistance
vessels, studies are not consistent with regard to the amount
of constriction and the dose required.10 Two investigations
of isolated, perfused Af of rabbits and mice demonstrated
a concentration-dependent, strong constriction, which was
more pronounced in the distal part of Af close to the
entrance into the capillary network of the glomerulus.11,12
In contrast, other investigators using the juxtamedullary
nephron preparation observed small and biphasic responses
upon cumulatively increased concentrations of Ado in rats.13
These conflicting results may be related to the differential
expression of A1AR in cortical glomerular arterioles com-
pared to juxtamedullary, and to differences in the method of
the analysis of arteriolar responses.10
Some studies point at a synergistic interaction between the
vasoconstrictor A1AR and angiotensin II (Ang II) type 1
receptors (AT1) in renal vasculature.
14 For instance, isolated,
perfused Af from mice lacking A1AR (A1AR(/)) show an
attenuated contractile response to Ang II.15 These studies
focused on actions of Ado on A1AR. Pilot studies in our
laboratory revealed a distinct influence of A2AR on the
response upon Ado in isolated, perfused Af. We therefore
tested the hypothesis of a contribution of several receptors
not only on arteriolar tone but also on the Ado–Ang II
interaction. We further investigated to which extent Ang II
influences the response of Af upon Ado.
RESULTS
KCl (100 mmol/l) applied at the beginning as well as at the
end of the experiment induced a constriction with complete
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closing of the lumen in all arterioles. Ado caused modest but
significant changes of luminal diameter. The response was
biphasic (Figure 1). Ado reduced the diameter to 92.571.6%
of the control value at 1010 mol/l. This constriction waned
at higher Ado concentrations (103.272.0% at 104 mol/l;
Figure 1). A dilation of arterioles was not limited by metho-
dical reasons, that is, the arterioles had a further dilatory
capacity, which was shown by the application of the NO
donor spermine NONOate (dilation to 111% of the control;
Figure 2). Treatment with Ang II led to a dose-dependent
constriction upon Ado (Figure 1).
The A1AR agonist N
6-cyclopentyladenosine (CPA) redu-
ced the luminal diameter in dependency on concentration
down to 87.973.5% (Figure 3). Cumulative application
of the A2AAR-selective agonist CGS21680 produced a di-
lation up to 113.071.6% (Figure 3). The blockade of the
vasoconstriction of Ado with the A1AR-selective antagonist
8-cyclopentyltheophylline (CPT) provides further evidence
that the vasoconstriction is mediated by A1AR (Figure 4).
Similarly, in mice lacking the A1AR, dilation was uniformly
the response (Figure 5).
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Figure 1 | Cumulative concentration–response curve for Ado
with (AdoþAng II, n¼ 7) and without treatment with Ang II
(n¼ 13) in C57BL6 mice. Absolute diameters (mm, upper panel)
and diameter in relation to the control value (%, lower panel) are
given (mean7s.e.m.). *Significance of concentration–response
(ANOVA), #differences in concentration-dependent course between
groups (ANOVA), ysignificant to control (con), and $significant
compared to Ado without Ang II.
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Figure 2 | Time course of the luminal diameter in percent of the
control value of Af in response to bolus applications of spermine
NONOate (n¼ 6) in C57BL6 mice. *A significant concentration–
response (ANOVA) and ysignificant to control (con).
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Figure 3 | Cumulative concentration–response curve for CPA
(n¼ 6) and CGS21680 (n¼ 5) in C57BL6 mice. *A significant
concentration–response (ANOVA) and ysignificant to control (con).
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The A1AR antagonist CPT, A2AAR-selective antagonist
ZM241385, or the combination of ZM241385 and MRS1706
(selective A2BAR antagonist) did not influence arteriolar tone
significantly (not shown).
Pretreatment with ZM241385 and MRS1706 or
ZM241385 alone caused similar monophasic constrictory
responses upon Ado (Figures 6 and 7), which differed from
pure Ado application. CPT and ZM241385 together did not
change the Ado response (Figure 8). Pretreatment with 8-SPT
(unspecific AR antagonist) neither changed arteriolar tone
nor the Ado response (Figure 8).
In A1(/) mice, the vessels dilated in dependency on
concentration upon Ado (Figure 5). The Ado concentra-
tion–response curve of A1(þ /þ ) differed significantly from
A1(/) and corresponded to that of the C57BL6 wild-type
mice. With regard to the absolute diameters (mm), Af of
A1(/) mice showed a strong tendency toward smaller
diameters in the control situation (not significant). There
were no differences in age, body mass, or gender distribution
between A1(/) and A1(þ /þ ) mice (not shown).
Cumulative application of inosine did not change luminal
diameter of Af from C57BL6 mice (Figure 9). Ado receptor
subtypes showed differential expression in isolated pre-
glomerular vessels. The expression was as follows: A1AR4
A2BAR4A2AAR4A3AR (Figure 10).
Cumulative application of Ang II resulted in a concen-
tration-dependent contractile response (Figures 11 and 12).
Ado treatment in a concentration of 108 mol/l increased
the Ang II response significantly (Figure 11). This was
prevented by CPT. Treatment with Ado in a concentration
of 105 mol/l did not change the Ang II response in Af
(Figure 12). Combined treatment with ZM241385 and
MRS1706 mimicked the effect of low concentrated Ado.
The control diameters of Af did not differ between these
series.
DISCUSSION
This study shows an impressive change of the Ado response
from a modest and biphasic course into a concentration-
dependent constriction of Af when Ang II is present in the
solution. Furthermore, it demonstrates that low concentra-
tions of Ado (108 mol/l) amplify the Ang II-induced cons-
triction of the Af. Higher concentrations of Ado (105 mol/l)
did not change the response of Af to Ang II. Latter effects
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Figure 4 | Effect of CPT (n¼ 6) on the concentration–response
curve of Ado (same data as in Figure 1, n¼ 13) in C57BL6 mice.
*Significant concentration–response (ANOVA), #difference in
concentration-dependent course between the groups (ANOVA),
and $significant compared with Ado.
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Figure 5 | Concentration–response curves for Ado in A1AR-
deficient mice (A1(/), n¼ 6) and their wild-type controls
(A1(þ /þ ), n¼ 5). *Significant concentration–response (ANOVA),
#significant differences in dose-dependent course between groups
(ANOVA), ysignificant compared with control (con), and $significant
compared with A1(/).
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are mediated by AR and may reflect the different affinity to
A1AR and A2BAR. It is assumed that the increase of the Ang
II response by lower Ado concentration is owing to the
synergistic action of AT1 and A1AR on phospholipase C.
16 We
show that the activation of A2BAR at higher Ado concentra-
tion interfere with this behavior.
Ado–Ang II interactions have been observed at the organ
level and in isolated, perfused arterioles before. For example,
only combined administration of Ado and Ang II induce
vasoconstriction in kidneys of dogs, although these drugs
alone do not significantly influence vascular resistance.1 Also,
the Ang II-induced constriction in Af of rabbits was
enhanced by Ado in excess of an additive effect.14 The idea
of an interaction between Ado and the Ang II system is
supported by results of a recent study showing a reduced
response of Af from mice lacking A1AR upon Ang II.
15
Conversely, the constrictor action of A1AR seems to
depend on AT1A receptors.
17 Deletion of AT1A receptors or
angiotensin-converting enzyme attenuates TGF responses in
knockout mice.17,18 Altogether, these studies indicate syner-
gistic interactions of Ado and Ang II, which are important for
renal blood flow control and TGF. The results of the present
study extend this view of Ado–Ang II interaction in Af. The
influence of Ado on the Ang II-induced contraction is
modulated by A1AR and A2BAR, whose differential activation
depends on the Ado concentration. Additionally, the study
demonstrates qualitative differences in the response of Af
to Ado, that is, a powerful increase of the constriction in
the presence of Ang II. This effect may be of importance in
the mediation of TGF by Ado.
A1AR and probably both A2AAR and A2BAR are involved
in the control of afferent arteriolar tone in the present study.
A1AR-mediated actions were demonstrated by the applica-
tion of CPA, which decreased luminal diameter, and by
CPT, which prevented the contractile response. The results of
experiments in A1(/) mice support the conclusions that
A1AR mediate constriction and that activation of A2AR leads
to dilation.
A differential effect of A2AAR and A2BAR can be estimated
considering the different affinity constants of A2AAR (about
108 mol/l) and A2BAR (about 10
5 mol/l) for Ado.19 Hence,
the observed fading of constriction of Af at high Ado concen-
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Figure 6 | Effect of ZM241385þMRS1706 on the concentration–-
response of Ado (n¼ 7) in C57BL6 mice. Same data as in Figure 1
for Ado response (n¼ 13). *Significant concentration–response
(ANOVA), #significant differences in concentration-dependent course
between groups (ANOVA), ysignificant compared with control (con),
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Figure 7 | Effect of ZM241385 (n¼ 6) and ZM241385þMRS1706
(n¼ 7) on the concentration–response of Ado in C57BL6 mice.
Same data as in Figure 6 for ZM241385þMRS1706. *Significant
concentration–response (ANOVA). Concentration-dependent course
do not differ between groups. ySignificant compared with
control (con).
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trations may be attributed to an occupation of A2BAR.
Further, the missing effect of treatment with high concentra-
tions of Ado on the Ang II-induced constriction suggests the
action of low-affinity A2BAR. Interestingly, A2AAR inhibition
with ZM241385 did not differ from combined A2AAR and
A2BAR blockade with ZM241385 and MRS1706. This obser-
vation would hint at a predominant role of A2AAR even at
higher Ado concentrations. However, a competitive action of
ZM241385 on A2BAR was described for concentrations as
used in the present study, which completely inhibit A2AAR.
20
Therefore, an attenuation of A2BAR-mediated effects cannot
be excluded. Arteriolar dilation upon the A2AAR agonist
CGS21680 supports the idea of a significant A2AAR function.
Notably, the treatment with ZM241385 did not enhance the
constrictory response upon Ado in the low-dose range, which
was expected assuming a balanced action of A1AR and A2AAR
at low Ado concentrations. In summary, the study provides
evidence for the role of both A2AAR and A2BAR in the control
of arteriolar tone. An exact functional characterization of the
subtypes is limited by the pharmacological means.
Our results regarding A2AR function are in agreement
with Tang et al.21 and Nishiyama et al.13 They described
afferent arteriolar dilation at submicromolar Ado concentra-
tions, which were probably mediated by high-affinity A2AAR.
Tang et al.21 also suggested activation of low-affinity A2BAR
by Ado concentrations higher than 105 mol/l.
The real-time polymerase chain reaction (PCR) of Ado
receptor mRNA in isolated preglomerular vessels (inter-
lobular arteries and Af) of C57BL6 showed expression for all
AR subtypes. The strongest mRNA expression was observed
for A1AR and A2BAR, which exceeded that of A2AAR. This
observation agrees with functional results from the present
study, which show that A2AAR and A2BAR exert a consider-
able dilatory action in Af of mice. The A3AR expression was
very low in the isolated vessels. This observation, and the fact
that the A3AR agonist inosine did not change arteriolar tone,
points to a negligible function of A3AR in the control of Af
under physiological conditions.
Interestingly, the constrictor effect of A1AR was enhanced
in the presence of Ang II (1010 mol/l). This strong
modification of the Ado response of Af by Ang II is more
than an additive effect. These data contribute to the expla-
nation of an attenuated TGF response in mice with deletion
of AT1A receptors or angiotensin-converting enzyme.
17,18
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Figure 8 | Effect of CPTþZM241385 (n¼ 4) and 8-SPT (n¼ 6) on
the concentration–response of Ado (same data as in Figure 1 for
Ado alone, n¼ 13) in C57BL6 mice. *Significant concentration–
response (ANOVA). There were no differences in the
concentration-dependent course between groups.
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Figure 9 | Cumulative concentration–response curve for inosine
(n¼ 6) and Ado (same data as in Figure 1 for Ado, n¼ 13) in
C57BL6 mice. *Significant concentration–response for Ado (ANOVA),
#significant difference in concentration–response between groups,
and $significant compared with Ado (con).
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The results of the present study partly disagree with results
of Ado effects in isolated, perfused Af of rabbits and
mice,11,12 where maximum reductions of luminal diameters
to about 45%11 and 30%12 were seen. Af constricted much
stronger in the part close to the entrance into the glomerular
capillary network. The authors postulated a non-homo-
geneous distribution of AR in Af with higher or sole
expression of A1AR at the very distal end. We did not see a
pronounced constriction at the distal site when applying Ado
or A1AR agonists. We can only speculate about reasons for
the differences in the Ado responses between the present
study and studies mentioned above. These include different
perfusion pressures and differences in preparation. For
example, in our preparations, the part of the distal tubule
adjacent to the glomerulus (macula densa) was always
preserved. This may reduce the variability of Af responses
as macula densa cells release vasoactive substances that
influence afferent arteriolar tone. In how far preservation
and partial preservation of macula densa cells, respectively,
affect the measurements in this model has not been
investigated yet.
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Figure 10 | Differential expression of Ado receptors in pre-
glomerular vessels of mice from the C57BL6 strain analyzed
with quantitative real time-PCR (n¼ 10). mRNA expression
is given in relation to the expression of b-actin in these vessels
(mean7s.d.). *Significant difference between groups.
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Figure 11 | Responses to Ang II (Ang II, n¼ 6), Ang IIþAdo
(108 mol/l, n¼ 6), and Ang IIþAdo (108 mol/l)þCPT (n¼ 10)
in C57BL6 mice. *Significant concentration–response, #difference
in the concentration–response compared to pure Ang II and Ang
IIþAdo 108 mol/lþCPT, respectively (ANOVA), and $significant
compared to Ado.
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Figure 12 | Responses to Ang II (Ang II, n¼ 6, same data as
in Figure 11), Ang IIþAdo (105 mol/l, n¼ 10), and Ang
IIþAdoþZM241385 and MRS1706 (n¼ 9) in C57BL6 mice.
*Significant concentration–response, #significant difference in the
concentration–response compared to Ang II pure and Ang IIþAdo
105 mol/l, respectively (ANOVA), and $significant compared to Ado.
Kidney International (2006) 70, 690–698 695
EY Lai et al.: Ado, Ang II, and afferent arterioles o r i g i n a l a r t i c l e
In conclusion, the present work shows the expression
of A1AR as well as A2AAR and A2BAR in Af and their
physiological role in the control of afferent arteriolar tone.
The response of Af upon Ado results from the action
of constrictor A1AR and dilatory A2AR, whose balance is
shifted in favor of A1AR at lower, and A2AR at higher Ado
concentration. Remarkably, Ang II clearly augments the
contractile response of Af to Ado. This points at a close
collaboration of both substances in mediating the TGF:
at physiological concentrations of Ang II, increased tubular
load induces the formation of ATP, which is released from
macula densa cells into the extracellular space. There, Ado
is formed and strongly sensitizes the contractile response of
Af. Furthermore, the data suggest a concentration-dependent
action of Ado on the Ang II sensitivity, which works via
differential activation of A1AR and A2AR. The potentiation
of the Ang II-induced constriction at low Ado concentrations
also may play a role in the TGF.
MATERIALS AND METHODS
Animals
Mice of the C57BL6 strain (male, body mass between 20 and 32 g,
Scanbur BK AB, Sollentuna, Sweden) were used for the investigation
of Ado receptor function in Af. Additionally, Ado A1AR receptor-
deficient mice (A1(/)) as well as their controls (A1(þ /þ ),
female, body mass between 23 and 29 g) were included to test the
effect of chronic lack of the A1AR receptor. A1(/) were generated
as described by Johansson et al.22 A1(/) and A1(þ /þ ) were
siblings from mating between A1(þ /) mice. Animals were fed
with standard mouse chow and allowed free access to tap water. All
procedures conformed to the Guide for Care and Use of Laboratory
Animals prepared by Institute for Laboratory Animal Research. The
local ethics committee for Uppsala University approved the
procedures for this study.
Dissection and perfusion
Dissection and perfusion procedures have been described before.23
In brief, outer cortical Af of mice were dissected at 41C in albumin-
enriched Dulbecco’s modified Eagle’s medium (0.1%). Arterioles
were perfused in a thermo-regulated chamber (371C) fixed on the
stage attached to an inverted microscope (Nikon, Badhoevedorp,
The Netherlands) using a perfusion system, which allows the
adjustment of outer holding and inner perfusion pipettes (Vestavia
Scientific, Vestavia Hills, AL, USA). The perfusion pipette, with a
diameter of the tip of exact 5 mm, was connected to a reservoir
containing the perfusion solution. The pressure in the pressure head
was 100 mmHg, which corresponds to physiological pressure and
flow (about 50 nl/min) in the connected Af.23 The criteria for using
an arteriole were a good, remaining basal tone and no pronounced
vasodilatation. Both criteria were tested by increasing the perfusion
pressure fast and assessing the change in the luminal diameter, which
corresponds to transient constriction. A further criterion was a fast
and complete constriction in response to KCl (100 mmol/l) solution.
Measurement of isotonic contraction
The experiments were recorded by a video system, off-line digitized,
and analyzed as described before.23 In all series, the last 10 s of the
2 min control or treatment period was used for statistical analysis of
steady-state responses.
Arterioles were used only in one protocol, which could include a
concentration–response curve with or without pretreatment. There
were no experiments included in which substances were washed out
or applied two times. This design is based on our observation of
sustained effects of agonists even when the control diameter was
reestablished after the washout.
Solutions
Dulbecco’s modified Eagle’s medium/F12 with 10 mmol/l HEPES
(Invitrogen AB, Lidingo¨, Sweden) was used for dissection, bath,
and perfusion. The pH was adjusted to 7.4 after the addition of
bovine serum albumin. The concentration of bovine serum albumin
was 0.1% in dissection and bath solutions, and 1% in the per-
fusion solution. Bovine serum albumin was obtained from SERVA
Electrophoresis (Heidelberg, Germany) and Dulbecco’s modified
Eagle’s medium from Sigma-Aldrich (Munich, Germany). The Kþ
solution had the following composition: NaCl 20, KCl 95, NaHCO3
25, K2HPO4 2.5, CaCl2 1.3, MgSO4 1.2, glucose 5.5 (mmol/l), and
was equilibrated with 5% CO2 in air.
Isolation of preglomerular vessels for receptor expression
analysis
Afferent arterioles of mice were isolated using a modified iron
oxide-sieving technique according to Chaudhari and Kirschen-
baum.24 Basic modification consisted in the perfusion of the
kidneys, which was performed via cannulation of the aorta, and
the use of smaller sizes for the needles used for separation of the
tissue, as well as of smaller pores of the sieves (100 and 80 mm). The
isolated vessels were transferred to a tube with 1000ml trizol and
immediately stored at 801C.
Quantitative real-time PCR
RNA was isolated using Trizol reagent and reverse transcribed using
Superscript and random hexamers (Invitrogen). Quantitative
PCR analysis was performed using a GeneAmp 5700 (Applied
Biosystems, Darmstadt, Germany). SYBR Green was used for the
fluorescent detection of DNA generated during the PCR. The PCR
reaction was performed in a total volume of 25 ml with 0.4 pmol/ml
of each primer, and 2 SYBR Green master mix (Applied
Biosystems, Darmstadt, Germany); 2 ml cDNA corresponding to
10 ng RNA was used as template. Primers, which bridge at least one
intron, were designed for PCR amplification on the basis of
published sequences for mouse: ADORA 1 (NM_009629), ADORA
2a (NM_009630), ADORA 2b (NM_007413), and ADORA 3
(NM_009631). The expression levels of Ado receptor mRNA were
analyzed according to the standard curve method and normalized
to b-actin.
Determination the standard curve for quantitative
real-time PCR25
PCR reactions for Adora1, 2a, 2b, 3, and b-actin were performed on
a Biometra T1 thermocycler using the real-time PCR primers. Each
PCR product was cloned into pCR&II-TOPO& vector using the
TOPO TA Cloning& Kit (Invitrogen, Karlsruhe, Germany) according
to the manufacturer’s protocol. Positive clones were identified by
PCR using vector- and insert-specific primers and grown overnight
in a 5 ml LB culture. Plasmids were isolated using QIApreps
columns (Qiagen, Hilden, Germany) according to the manu-
facturer’s protocol. Quantification of DNA was performed on a
Beckman DU-600 UV spectrometer at OD260 nm. For standard
curve acquisition, four serial factor 0.5 dilutions of plasmid DNA
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were prepared serving as DNA templates for real-time PCR. Real-
time PCR using SYBR Green technology (Applied Biosystems,
Darmstadt, Germany) with the above-mentioned primers was
carried out amplifying cloned sequence in triplicate for each
respective concentration. Subsequently, a melting curve program
was applied with continuous fluorescence measurement to check the
quality of the PCR product. Linear regression was applied to
determine the relationship between logarithm of concentration and
ct values and to obtain the coefficients for the transfer function.
Pharmacological agents
The following drugs were used: Ang II, Ado, inosine (A3AR agonist),
CPA (selective A1AR agonist), 2-p-(2-carboxyethyl)phenethylamino-
50-N-ethylcarboxamido Ado (CGS21680, selective A2AAR agonist),
CPT (selective A1AR antagonist), 8-(p-sulfophenyl)theophylline (8-
SPT, non-selective AR antagonist), [N-(2-aminoethyl)-N-(2-hydro-
xy-nitrosohydrazino)-1, 2-ethylenediamine] (spermine NONOate,
NO donor) from Sigma-Aldrich (Stockholm, Sweden), and 4-(2-
[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]
ethyl)phenol (ZM241385, selective A2AAR antagonist) and N-(4-
acethylphenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-
purin-8-yl)phenoxy]-acetamide (MRS1706, selective A2BAR anta-
gonist) from Tocris Cookson Ltd (Bristol, UK).
Statistics
Analysis of variance (ANOVA) for repeated measurements (non-
parametric Brunner test) was used to test concentration- and time-
dependent changes in the arteriolar diameter (one-way ANOVA)
and to check for differences between the groups (two-way ANOVA,
SAS systems, SAS Institute, Cary, NC, USA). One-way ANOVA was
combined with the Tuckey post hoc test (modified t-test for paired
comparisons). Differences between groups were tested using the
Kruskal–Wallis- and Mann–Whitney test. The Wilcoxon test was
applied for the comparison of treatment effect on control diameter.
Data are presented as mean7s.e.m., unless otherwise noted. The
confidence level P was set to 0.05 for all statistical tests.
Protocols
The concentration–response curve for Ado was obtained by
cumulative application to the bath solution (1011–104 mol/l). To
test the dilatory capacity of the vessels, the NO donor spermine
NONOate was applied as a bolus (5 104 mol/l) and the vessel’s
diameters were measured for following 15 min. For investigation of
A1AR-mediated effects on Af, the concentration–response curve of
CPA (selective A1AR agonist, 10
11–106 mol/l) was measured.
Further, the Ado concentration–response curves for A1(/) mice
and their wild-type controls (A1(þ /þ )) were generated. Func-
tional characterization of Ado receptors was also carried out by
treatment with CPT (selective A1AR antagonist, 10
5 mol/l),
CGS21680 (selective A2AAR agonist, 10
12–104 mol/l), ZM241385
(selective A2AAR antagonist, 10
7 mol/l), the combination of CPT
and ZM241385 (107 mol/l), as well as ZM241385 and MRS1706
(selective A2BAR receptor antagonist, 10
6 mol/l), 8-SPT (non-
selective Ado receptor antagonist, 5 105 mol/l), and a following
parallel application together with Ado (1011–104 mol/l), except for
CGS21680. A possible function of A3AR
26 was tested by application
of inosine (1011–104 mol/l).
The interaction of Ado and Ang II was evaluated by several
protocols. The concentration–response of Ang II (1014–106 mol/l)
was measured while treatment with Ado (108 or 105 mol/l). We
tested the role of Ado receptors in the interaction by applying the
selective A1AR antagonist (CPT) together with Ado 10
8 mol/l, and
A2AAR receptor antagonist (ZM241385, 10
7 mol/l) combined with
a selective A2BAR receptor antagonist (MRS1706, 10
6 mol/l)
together with Ado 105 mol/l, respectively. Furthermore, to check
the influence of Ang II on the response of the arteriole to Ado,
Ang II (1010 mol/l) and Ado (1011–104 mol/l) were applied
simultaneously.
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